首页
登录
职称英语
Small, pink and very ugly. Hardly the qualities of a star, but they describe
Small, pink and very ugly. Hardly the qualities of a star, but they describe
游客
2025-05-08
23
管理
问题
Small, pink and very ugly. Hardly the qualities of a star, but they describe the deformed mouse that was the media darling at a recent science exhibition in Beijing. With a complex tissue structure in the shape of a human ear grafted on to its back, the rosy rodent was a stunning symbol of the serious strides China is making in the field of biotechnology.
China is fast applying the latest life-science techniques learned from the West m aggressively pursue genome research. It’s establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China and in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.
For the moment, the cooperation exists mostly with Europe and the U. S. But Asia’s other biotech leaders, Japan, Singapore and Korea, also are recognizing China’s potential as an attractive low-cost base to conduct research. These partnerships--and China’s advancement in the field of biotechnology--could help benefit the rest of Asia: China’s rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population--and those of other Asian countries--can afford.
There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safety Protocol, which should mean adherence to global standards governing the conduct of field trims. But some observers are skeptical. "The regulations look good, but I haven’t met one scientist who believes they are being fully adhered to," says a European science analyst.
If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab tests are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China. [br] Japan, Singapore, and Korea will also be interested in cooperating with China in biotechnology because ______.
选项
A、it has made extraordinary contributions to the world
B、it has large supplies of talents and advanced research centers
C、its research focuses on the benefits of all Asian countries
D、its cooperation with the US and Europe proves profitable
答案
B
解析
转载请注明原文地址:https://tihaiku.com/zcyy/4067308.html
相关试题推荐
Small,pinkandveryugly.Hardlythequalitiesofastar,buttheydescribe
Small,pinkandveryugly.Hardlythequalitiesofastar,buttheydescribe
Small,pinkandveryugly.Hardlythequalitiesofastar,buttheydescribe
Small,pinkandveryugly.Hardlythequalitiesofastar,buttheydescribe
Hardly______whenaloudexplosionwasheard.A、thetrainhadstartedB、thetrai
Tomcouldhardly______hisexcitementasheknewthathehadmadearealdiscov
OneworddescribeswhatmakesSingaporework:discipline.A、punishmentB、regulati
Anoldwomanwasbadlyhurtin______thepolicedescribeasanapparentlymotiv
Therewas(hardlysomebody)intheroomwhopaid(any)attentiontohim(eventh
Theword"foolish"istoomildtodescribeyourbehavior,Iwouldpreferthewor
随机试题
Successfulsportsprofessionalscanearnagreatdealmoremoneythanpeople
BACHELOROFARTS-PRODUCTDESIGNAwarde
下列对于本公文的附件及成文日期的叙述,错误的是:() A.附件说明位置错误
患者,男,35岁,已婚,咽痛发热1周,在内科诊为"化脓性扁桃体炎",给予口服罗红
建设工程项目开工前,工程质量监督的申报手续应由项目()负责。A:建设单位
药物化学研究可提供A.新的原料药生产工艺 B.新的药理作用模型 C.新的药品
鉴别肱骨髁上骨折与肘关节脱位,主要检查A:有无出血 B:有无异常活动 C:肘
简述几种新兴的教育研究方法。
某医生欲了解A、B两药治疗某病的疗效有无差别,将某病患者随机分为两组,分别用A、
根据《环境影响评价技术导则地面水环境》,在进行水质预测时,关于河流简化的说法,错
最新回复
(
0
)